Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. （開啟新視窗）

Ball AM, Winstead PS.

來源‎: Pharmacotherapy 2008;28(11):1383-90.

檢索‎: PubMed 18956998

DOI碼‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 （開啟新視窗）

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. （開啟新視窗）

Charles A, Purtill M, Napolitano LM.

來源‎: Anaesth Intensive Care 2006;34(6):793-6.

檢索‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 （開啟新視窗）

Thalidomide for recurrent bleeding due to small-intestinal angiodysplasia. （開啟新視窗）

Chen H, Wu S, Tang M, Zhao R, Zhang Q, Dai Z, Gao Y, Yang S, Li Z, Du Y, Yang A, Zhong L, Lu L, Xu L, Shen X, Liu S, Zhong J, Li X, Lu H, Xiong H, Shen Y, Chen H, Gong S, Xue H, Ge Z

來源‎: N Engl J Med. 2023 2;389(18):1649-59.

檢索‎: PubMed 37913505

DOI碼‎: 10.1056/NEJMoa2303706

https://pubmed.ncbi.nlm.nih.gov/37913505/ （開啟新視窗）

Bloodless management of the anemic patient in the emergency department. （開啟新視窗）

Johnson-Arbor K, Verstraete R

來源‎: Ann Emerg Med 2022;79(1):48-57.

檢索‎: PubMed 34353645

DOI碼‎: 10.1016/j.annemergmed.2021.06.015

https://pubmed.ncbi.nlm.nih.gov/34353645/ （開啟新視窗）

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. （開啟新視窗）

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

來源‎: J Trauma 2008;65(2):285-97.

檢索‎: PubMed 18695463

DOI碼‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 （開啟新視窗）

Erythropoiesis in multiply injured patients. （開啟新視窗）

Robinson Y, Hostmann A, Matenov A, Ertel W, Oberholzer A.

來源‎: J Trauma 2006;61(5):1285-91.

檢索‎: PubMed 17099548

DOI碼‎: 10.1097/01.ta.0000240969.13891.9b

https://www.ncbi.nlm.nih.gov/pubmed/17099548 （開啟新視窗）

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. （開啟新視窗）

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

來源‎: Arch Surg 2012;147(3):251-5.

檢索‎: PubMed 22430906

DOI碼‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 （開啟新視窗）

Zeugen Jehovas und Schwerverletzung mit drohender Hämorrhagie. Wie komplex ist die Behandlung? [Jehovah's Witnesses and severe injury with impending hemorrhaging: how complex is the treatment?] [German, English abstract] （開啟新視窗）

Zeckey C, Vanin N, Neitzke G, Mommsen P, Bachmann S, Frink M, Wilhelmi M, Krettek C, Hildebrand F.

來源‎: Chirurg 2011;82(6):531-5.

檢索‎: PubMed 21088815

DOI碼‎: 10.1007/s00104-010-1999-y

https://www.ncbi.nlm.nih.gov/pubmed/21088815 （開啟新視窗）